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The first layer of defense that plants deploy to ward off a microbial invasion comes in the form of pattern-
triggered immunity (PTI), which is initiated when the pattern-recognition receptors (PRRs) bind with the
pathogen-associated molecular patterns (PAMPs) and co-receptor proteins, and transmit a defense
signal. Although several plant PRRs have been discovered, very few of them have been fully
characterized, and their functional parameters assessed. In this study, the 3D-model prediction of an
entire plant PRR protein, Xa21, was done by implementing multiple in silico modeling techniques.
Subsequently, the PAMP RaxX21-sY (sulphated RaxX21) and leucine-rich repeat (LRR) domain of the co-
receptor OsSERK2 were docked with the LRR domain of Xa21. The docked complex of these three
proteins formed a heterodimer that closely resembles the other crystallographic PTI complexes available.
Molecular dynamics simulations and MM/PBSA calculations were applied for an in-depth analysis of the
interactions between Xa21 LRR, RaxX21-sY, and OsSERK2 LRR. Arg230 and Arg185 from Xa21 LRR, Val2
and Lys15 from RaxX21-sY and Lys164 from OsSERK2 LRR were found to be the prominent residues
which might contribute significantly in the formation of a heterodimer during the PTI process mediated
by Xa21. Additionally, RaxX21-sY interacted much more favorably with Xa21 LRR in the presence of
OsSERK2 LRR in the complex, which substantiates the necessity of the co-receptor in Xa21 mediated PTI
to recognize the PAMP RaxX21-sY. However, the free energy binding calculation reveals the favorability
of a heterodimer formation of PRR Xa21 and co-receptor OsSERK2 without the presence of PAMP
RaxX21-sY, which validate the previous lab result.Introduction
Plants employ a two layered defense mechanism to confront
bacterial and fungal pathogens. The rst layer of defense is
termed pattern-triggered immunity (PTI), which is the focus of
the current study; and the second layer is called effector trig-
gered immunity (ETI).1–3 PTI is triggered upon the recognition
of a conserved microbial signature by the host leucine-rich
repeat (LRR) domain of pattern recognition receptors (PRRs).4
Based on their location in the cell, PRRs are classied as
membrane-bound PRRs and cytoplasmic PRRs. Subsequently,
membrane bound plant PRRs which confers innate immunity
are classied into receptor-like proteins (RLPs), which do notciences, BRAC University, 66 Mohakhali,
assir@bracu.ac.bd
g, Universiti Teknologi Malaysia, 81310
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15814have a kinase domain; and receptor-like kinases (RLKs), which
have a well-dened kinase domain.5–9 Plants have a greater
number of both RLPs and RLKs compared to animals10 and
there are more RLKs than RLPs. While the rice plant has 640
RLKs, the Arabidopsis plant only has around 410 RLKs.10–12
There are four vital roles played by RLKs, which are sensing the
extracellular signals such as peptides or ligands, activate
receptor proteins, carry out downstream signals, and antici-
pating protein interaction sites and make sizable signaling
networks.13
PRR in Arabidopsis such as agellin-sensitive 2 (FLS2) was
well characterized experimentally14 while the tertiary structure
of PRR protein in rice known as Xa21, is yet to be resolved.
FLS2 and Xa21 both fall under the protein XII sub-family
(leucine-rich repeat-receptor kinase, LRR-RK XII). Sub-family
XII is one of the most expanded of LRR-RK families in rice,
which encode mostly for PRRs or PRR-associated RKs.15 Xa21
also shows enormous similarity in defense signaling both with
animal toll-like receptors (TLRs) and EF-Tu receptors, besides
FLS2.7,16,17
Due to the presence of Xa21, rice plants show robust resis-

























































































View Article Onlineoryzae pv. oryzae (Xoo).18,19 BLB is regarded as a major disease in
rice20 which can cause yield loss of up to 70%.21 The best control
and by far the most cost effective approach has been the usage
of resistant cultivars.22,23 Xa21 has 23 leucine rich repeats in its
LRR domain, one transmembrane (TM) domain, one juxta-
membrane (JM) domain and one kinase domain.24 The LRR
domain, which is localized outside of the plant membrane,
binds to the bacterial peptide, RaxX21 secreted by Xoo. During
bacterial secretion, the RaxX21 becomes sulfated in the tyrosine
region (RaxX21-sY).25 This, in turn, imparts increased stability
to the peptide, leading to the initiation of the subsequent task
of binding to Xa21 and initiating a signal.26 Consequently, this
signal passes through the TM domain and JM domain to the
kinase domain, activating the PTI which leads to the association
of the co-receptor protein OsSERK2 with Xa21, triggering the
plant defense mechanism.27 Plants without PRR Xa21 shows
susceptibility to the RaxX21-sY generating Xoo strain, and
interestingly plants with PRR Xa21 cannot recognize Xoo strain
without the presence of RaxX21-sY.25,28–30
For other similar cases like FLS2, its LRR domain binds to
g22 which is a 22 residue epitope situated at the N terminus of
agellin from Gram-negative bacteria with the help of cor-
eceptor BAK1 to trigger PTI.14 For BRI1, another well charac-
terized PTI complex, its LRR domain binds with the co-receptor
SERK1 and forms a heterodimer where the PAMP brassinolide
acts as a molecular glue.31 Besides activating the defense
mechanism, several other PRRs are also involved in controlling
the growth and development of the plant, such as HAESA,32
formerly known as RLK5, which recognizes the IDA to control
the oral organ abscission.
Only about 2% of all membrane bound proteins have been
crystallized and the information added to the protein data
bank (PDB).33 Also, no crystallographic structure of entire
plant PRRs are available in the PDB to date, only partial
structures are available (such as LRRs or kinase domains). As
Xa21 is a membrane bound PRR with a complicated four-
component conguration, no structure of Xa21 has yet been
determined experimentally, therefore in silico modeling
approaches were implemented to predict a structural model
of Xa21.
Furthermore, the modeled LRR domain of Xa21 was docked
with PAMP RaxX21-sY and co-receptor OsSERK2 LRR, and
molecular dynamics (MD) simulations and MM/PBSA free
energy binding calculations were performed to get a better
understanding on binding mechanism of the PAMP RaxX21-sY,
co-receptor OsSERK2 and the PRR Xa21. Besides, the MD
simulation and MM/PBSA calculation of different complexes of
the Xa21 provides important insight on the contribution of the
PAMP RaxX21-sY and co-receptor OsSERK2 in the formation of
the heterodimer complex for PTI. We believe that, the outcome
of this study will not only contribute signicantly towards the
understanding of the structural details and functional aspects
of PRR Xa21, but also its interaction with PAMP RaxX21-sY and
co-receptor OsSERK2 LRR, as well as their individual contri-
butions in Xa21 mediated immunity.This journal is © The Royal Society of Chemistry 2020Materials and methods
Sequence based analysis and delineation of the domain
boundary
Amino acid (AA) sequence of the target Xa21 protein was
retrieved from Uniprot KB with the accession number Q40640
and the sequence was originally reported to the database by
Song et al. in 1995.24 The ProtParam tool was employed to
analyze the primary structure and to predict the physio-
chemical properties,34 whereas the secondary structure was
predicted using PSIPRED (V3.3)35 and SOPMA.36 To identify the
conserved region of the sequence the ConSurf tool37 was used.
To investigate the domain architecture InterPro,38 SMART,39
lrrnder.com40 and HHrepID41 tools were used. PREDICT
PROTEIN,42 TMHMM,43 MEMSAT-SVM44 and SOSUI45 tools were
used for predicting the transmembrane region.
Single template modeling
NCBI BLASTP46 and HHpred47 analysis for homology detection
of Xa21 AA sequence was carried out against the Protein Data
Bank (PDB) using default parameter values to search for suit-
able templates for Xa21. Then different single template
modeling approaches were implemented (Table S1A†) such as –
Modeller 9.15,48 3D-JIGSAW,49 CPHmodel 3.2,50 Geno3D,51
PRC,52 Prospect 2,53 pGenTHREADER,54 FFAS-3D,55 FFAS03,56
SP3,57 Sparks-X,58 Swiss-Model,59 MUSTER60 and wdPPAS.61
Multiple template modeling
Multiple sequence alignment (MSA) of the top ve templates
(according to lowest e-value resulted from BLASTP) and the
target sequence was carried out using the Praline tool.62 The
result illustrated a comparative analysis of the template
sequence against the target sequence and helped visualize the
template sequence coverage of the target sequence. MSA
(Fig. S1a†) showed that the templates only covered either the
LRR region or the kinase domain of Xa21. The domain
boundary was then set to Xa21 N-terminal, LRR (AA 1–634),
Xa21 kinase, JM, TM charged1 (c1), TM charged2 (c2) and C-
terminal (AA 635–1025) regions to see if any of the templates
coveredmore than one domain of Xa21. Then a secondMSA was
performed using the entire sequence of Xa21 containing all the
domains with top ve complementary template sequences for
the LRR domain, while a third MSA was carried out using the
entire target sequence of Xa21 against top ve complementary
template sequences for the kinase domain which resulted from
the latest blast (Table S2A†).
From the second and third MSAs (Fig. S1b and c†), it was
evident that there was no overlap of the kinase, JM, and TM
regions with the LRR template; while some of the kinase
domain templates had overlapping regions with the JM domain
region of the Xa21 protein. The results also showed that the N-
terminal region (AA 1–26) and C-terminal region (AA 1010–1025)
had no corresponding aligned regions and played no part in the
PAMP or co-receptor binding. Therefore, these two regions were
omitted from the target sequence. Also, from the results of the

























































































View Article Onlinecomplementary sequence for the TM region. Then NCBI
BLASTP was again carried out for Xa21 TM, c1 and c2 (AA 651–
707) regions to search for a suitable template for the TM region.
But no complementary template was found.
Again, from the third MSA (Fig. S1c†), it was observed that
the kinase domain showed overlaps with the JM domain. To
nd out templates for the kinase and JM domains, NCBI
BLASTP was carried out using respective query sequences and
the top ve templates were selected to be used in multiple
template modeling. In all cases, the same structure with
different PDB ID was avoided.
For LRR domain modeling with the HHpred server, the top
ve templates were selected from BLASTP results (Table S2A†).
Five templates were selected because of the HHpred server's
recommended use of a maximum of ve templates for each
domain. All combinations for the 5 templates were considered
for building models of the LRR domain (Table S1B†). According
to the equation below a total of 31 models were built. The same









where, n – total number of templates (which is always ve in this
case); k – number of templates being used for a particular
combination.
As NCBI BLASTP could not nd any template sequences for
TM region, the HHpred server was used instead and two
templates were found with reasonable e values (Table S2B†).
Hence for modeling the TM region, the combination of these
two templates (making it a total of three) was used.
For modeling the nal Xa21 protein with the HHpred server,
the individual domain models modeled by the HHpred server
(which were evaluated to be the best) were taken into consid-
eration. Finally, modeling was done using the best template/
combination of templates of these domains (Fig. 1).
Other multiple template modeling tools, having different
modeling principles, such as Phyre2 intensive modeling,63
Raptor-X,64 I-TASSER65 and AIDA66 were also used to model
Xa21; to ascertain that the nal model chosen for further
studies was the best possible one. All these tools are automated
protein modeling servers where Phyre2 is a homology-based
prediction tool and uses Poing (an ab initio tool) to predict
small fragments where homology is missing, Raptor-X is based
on threading, I-TASSER is based on both threading and ab ini-
tio, and AIDA is a homology based multiple template modeling
server.Structure validation
To analyze the geometry, structural consistency and reliability
of the predicted structures, multiple tools were employed. To
evaluate the non-bonded interactions between different types of
atoms, ERRAT67 was used, while Verify-3D68 was employed for
assessing the compatibility of the atomic models by subjecting
them to their own AA sequences. For geometrical consistency
analysis, Ramachandran plots generated by PROCHECK69 were15802 | RSC Adv., 2020, 10, 15800–15814assessed. The quality of these proteins were also visually
analyzed using PyMOL.70 The quality of the nal models was
again checked in more detail using ProQ,71 ProSA,72 VADAR,73
and MolProbity.74
Docking of Xa21 LRR with its PAMP RaxX21-sY and co-
receptor OsSERK2 LRR
For investigating the interaction of PAMP RaxX21-sY and co-
receptor OsSERK2 LRR with its PRR Xa21, only the LRR
region of the Xa21 protein was taken into consideration, as only
LRR portion of the protein is enough to initiate the defense
signal.32,75–79 The best LRR structure of Xa21 (Xa21lrr_15) and
the RaxX21-sY modeled in our previous study26 were energy
minimized and equilibrated. A 2 ns NVT equilibration followed
by a 1 ns NPT equilibration was performed. The subsequent
energy minimized and equilibrated structures were used as
initial protein structures for docking using the protein–protein
docking tool ZDOCK.80 The top 10 predictions were obtained
from docking results and the best structure, according to the
binding similarity with other crystallographic structures, was
carefully selected. Following the same protocol OsSERK2 LRR
(PDB ID: 4q3g) was docked with the complex of Xa21 and
RaxX21-sY, and complex 1 (Xa21 LRR with its PAMP RaxX21-sY
and co-receptor OsSERK2 LRR) was prepared for a MD simula-
tion. The 27th AA glycine of Xa21 LRR was considered to be the
1st AA and the results of the prediction were analyzed accord-
ingly. To get an idea about the contribution of co-receptor
OsSERK2 and PAMP RaxX21-sY, two other complexes were
made from complex 1 which were complex 2 (by removing
PAMP RaxX21-sY from the complex 1) and complex 3 (by
removing co-receptor OsSERK2 from the complex 1).
MD simulation of Xa21 LRR, RaxX21-sY and OsSERK2 LRR
complexes
All three complexes were subjected to MD simulation with
GROMACS81 soware suite (version 5.1). GROMOS 54a7 (ref. 82)
united force eld was employed for the simulation process,
using water as a solvent. For solvation, cubic boxes were made
with a minimum distance of 1A between the surfaces and edges
of the complexes and were solvated with the SPC water model.83
Aer neutralizing the systems with the Genion tool, energy
minimization was done for all the systems. Then the systems
were equilibrated for 2 ns NVT ensemble followed by 1 ns NPT
ensemble maintaining a constant 300 K temperature and 1 atm
pressure, respectively. Finally, a 100 ns MD simulation was
carried out for each complex. Particle Mesh Ewald (PME)
method was applied to treat the long-range electrostatic inter-
actions. Root mean square uctuations (RMSF) were calculated
using the GROMACS tool to monitor the prominent residues of
the proteins inside the complexes.
Analysis of binding mode of Xa21 LRR with RaxX21-sY and
OsSERK2 LRR
Binding mode of Xa21 LRR, RaxX21-sY and OsSERK2 LRR
complex was assessed using UCSF Chimera.84 Besides, the
complex was compared with other similar crystallographicThis journal is © The Royal Society of Chemistry 2020

























































































View Article Onlinestructures obtained from the protein data bank, consisting of –
the crystal complex of FLS2 LRR-g22-Bak1 (PDB ID: 4mn8),
PEPR1-AtPep (PDB ID: 5gr8), BRI1-brassinolide-BAK1 (PDB ID:
4lsx) and HAESA-IDA-SERK1 (PDB ID: 5iyx).
For analyzing the individual residue contribution during
binding of Xa21 LRR with RaxX21-sY and OsSERK2 LRR, MM/
PBSA and protein interaction calculator (PIC) were employed.
MM/PBSA is a post-processing method where the free energy of
a state is determined from the interior energy (MM) of the
residues and its connection with an understandable portrayal of
solvent (PBSA).85 For MM/PBSA calculation, the g_mmpbsa86
tool was used which is developed by using GROMACS and ABPS
tools. g_mmpbsa computes binding energy of bio molecular
affiliations like protein–protein, protein–ligand, protein–DNA
etc. It gives the distinctive segment of energy term inThis journal is © The Royal Society of Chemistry 2020independent record with the goal of having either MM, PB and
SA energy esteems or all of them. Moreover, in the g_mmpbsa
tool, two types of python scripts (MmPbSaStat.py and
MmPbSaDecomp.py) were used to calculate the average binding
energy and its standard deviation/error and the nal contribu-
tion energy of each residue from individual energetic terms.
For the MM/PBSA calculation, complex 1 was divided into
three different sub-complexes which are complex 1a, 1b and 1c
as the tool can only calculate the binding energy between two
proteins. Complex 1a is comprised of Xa21 LRR and RaxX21-sY,
complex 1b contains Xa21 LRR and OsSERK2 LRR and complex
1c consists of RaxX21-sY and OsSERK2 LRR. Similar protocols
were followed for MM/PBSA calculation in case of complex 2

























































































View Article OnlineBy using PyMOL87 and UCSF Chimera84 all the structures and
the intermolecular interactions among Xa21 LRR, RaxX21-sY
and OsSERK2 LRR were visualized. H-bonds, hydrophobic
interactions, ionic interactions, aromatic interactions and
cation–pi interactions between these proteins were measured
using the tool protein interaction calculator (PIC). All these
analyses were done for each of the docked complexes both
before and aer the simulations.
Results and discussion
Sequence based analysis and delineation of the domain
boundary
The primary structure of Xa21 was analyzed using the Prot-
Param tool. Xa21 is a relatively large protein containing 1025
amino acids. A theoretical estimate of the molecular weight of
Xa21 is 111.34 kD which is lower than that of the experimentally
measured value. The isoelectric point (pI) of Xa21 was
computed to be 7.35, suggesting that the protein is slightly
alkaline. The aliphatic index (109.69) and the instability index
(32.79) of Xa21 suggested that the protein is thermostable.
Finally, the GRAVY value (0.049) indicated that Xa21 is hydro-
phobic in nature. Since Xa21 has zero net charge and is
hydrophobic in nature, Xa21 is not likely to be an intrinsically
disordered protein.
SOPMA was used to make the following predictions about
the secondary structure – alpha helix 35.12%, extended strand
18.15%, beta turn 8.49% and random coil 38.24%, while no 310
helix, pi helix, beta-bridge, bend region and ambiguous states
were found. A detailed observation of the SOPMA results
showed that the transmembrane region (658–672) was most
likely predicted as the alpha helix. The secondary structure
predicted by PSIPRED (Fig. S2†) was consistent with that of
SOPMA.
The ConSurf tool was used to predict the conserved regions
of Xa21. On the basis of the calculations which portrayed
a sufficiently low evolutionary rate, the kinase domain (708–
799) was predicted to be the conserved region (Fig. S3a†). The
other regions such as N-terminal, C-terminal, TM domain and
LRR domain were classied as variable regions as those regions
had a relatively higher evolutionary rate.
To perform functional annotation of the Xa21 protein
sequence, the InterPro tool was used. InterPro reported two LRR
domains, one protein kinase like domain and one concanavalin
A-like lectin/glucanase domain (Fig. S3b†). It also detected
a protein kinase ATP binding site and a serine/threonine–
protein kinase active site. The detected LRR domain, kinase
domain and two sites are very relevant to Xa21's function.
Though the role of concanavalin A-like lectin/glucanase domain
in Xa21 is not clear, it is suspected to serve as a carbohydrate
receptor. The SMART tool was used to explore the domain
architecture of Xa21 and the search revealed that Xa21 is
composed of 12 LRRs in its domain, one transmembrane
domain and one kinase domain (Fig. S3c†). To further investi-
gate the LRR region, lrrnder and HHrepID tools were used.
Lrrnder detected 13 signicant hits for LRR domain and
HHrepID predicted 23 LRRs in a domain (Table S3†), which is15804 | RSC Adv., 2020, 10, 15800–15814composed of 24 AA (Fig. S3d†). Among all LRR domain
predictions, the HHrepID prediction matched with previous
ndings by Song et al., 1995.88
The transmembrane region predicted by Predict Protein was
from AA 656 to 675 whereas TMHMM and SOSUI predicted AA
652 to 674, andMEMSAT-SVM predicted AA 653–675 residues of
Xa21 (Fig. S3e†). These predictions were similar to previous
ndings by Song et al., 1995.24 Also, the resulted LRR domain
has a consensus sequence LxxLxxLxLxxNxLSGxIPxxLGx which is
very unique to plant LRRs which creates a twisted or helical
horseshoe like structure.31
Single template modeling
NCBI BLASTP analysis of the 1025 AA sequence of Xa21 protein
resulted in several templates according to the query coverage, e-
value and identity. Among the templates, 4mnA (FLS2 ectodo-
main) has the highest score (340) with the lowest e-value (8e-
103). The suggested template sequence has 36.65% identity
and 58% coverage with the query sequence. HHpred also re-
ported 4mn8A to be the best template for modeling Xa21 with
an e-value of 6.6  1042 and a maximum score of 425.3.
Default parameters were used for modeling Xa21 using
Modeller (version 9.15). It produced ve of the best models and
the model with the lowest DOPE score (91 944.44531) was
taken under consideration for further validation. Other
homology modeling tools such as 3D-JIGSAW, CPHmodel 3.2,
Swiss-Model and Geno3D failed to produce a working model of
the entire protein containing all the amino acids of Xa21.
Another attempt was also made to build a model of Xa21 using
a local meta-threading server, LOMETS. LOMETS server uses
ten locally installed threading programs such as FFAS-3D,
MUSTER, pGenTHREADER, PPAS, PRC, PROSPECT2, SP3 and
SPARKS-X, and none of the programs were able to model the
entire protein of Xa21 (Fig. S4†).
Multiple template modeling
Through the visual screening using PyMOL and the use of
different validation servers the quality of the different protein
structures was assessed (Table S4†) and it was evident that
model Xa21lrr_15 built from the ve templates (4mn8A + 4u08A
+ 4j0mA + 3rgzA + 1ogqA) is the best LRR domain model among
all the 31 models generated using the HHpred server. The
ERRAT score of 63.167 suggested that the generated model is
robust. The Verify-3D result turned up a 100% which indicates
excellent compatibility of the model with its own AA sequence.
Ramachandran plot analysis from Procheck showed that 98.2%
(70.6 + 26.6 + 1) of residues are in the allowed region, which
indicates that the model is of very high quality.
For the kinase domain containing JM domain and C
terminal, model Xa21k_1 built from only one template (4oh4A)
gave the maximum ERRAT score. Verify-3D result also showed
signicant compatibility (84.71%) of the model with its own AA
sequence. The Ramachandran plot also showed that 99.7%
(90.6 + 7.7 + 1.4) of the residues were in the allowed region
which dictates that the generated model is of very high quality.

























































































View Article OnlineXa21c12tm_3 built from templates 2jwaA and 2ks1B gave the
best ERRAT score (81.579) and 100% residues are also in the
allowed region of the Ramachandran plot (Table S3†). All these
eight templates (4mn8A + 4j0mA + 3rizA + 1ogqA + 4u08A + 2jwA
+ 2ks1B + 4oh4A) were determined to be the best for all indi-
vidual domains and so were selected for the nal modeling of
Xa21 (AA 27–1009) using the HHpred server.
In addition to the HHpred server, Phyre2 suite was also used
to model the Xa21 protein. In Phyre2 intensive model, 8
templates were fed into Phyre2 and heuristics was applied to
maximize condence, percent identity and alignment coverage.
A total of 91% of residues were modeled at >90% condence
and 90 residues were modeled by a combination of homology
and ab initio method. Since it has >90% condence level and
high identity, we assumed that the predicted model is fairly
accurate.
The Raptor-X tool predicted two domains (modeling unit) in
multiple template modeling of Xa21. Domain1 is of LRR region
and domain2 is of TM, JM and kinase domain portions. In the
case of domain-1modeling, 4mn8A was selected as the template
and for modeling domain-2 3tl8A, 4oa2A and 4oa6A were
selected as templates.
Top ten threading templates were selected from the tool I-
TASSER, based on the highest Z-score of each threading align-
ment of LOMETS from thousands of threading alignments. Five
models were generated according to low C-score values and
nally the model with the lowest C-score (2.05) was selected
for validation.
AIDA predicted two domains – domain1 and domain2, for
Xa21 protein modeling and domain2 was further divided into
domain2.1 and domain2.2. 4mn8A template was used for
modeling domain1, 2jwaA for modeling domain2.1 and 4l68A
for domain2.2. Finally, all the domains were assembled to
completely model the Xa21 protein.
Structure validation of models for single template modeling
approach
Screening (Fig. S4†) of the Xa21 proteins generated by single
template modeling approach gave us an idea about the multi-
domain protein modeling capability of these tools. Among
single template-based tools, 3D-JIGSAW, CPHmodel 3.2,
Geno3D and Swiss-Model could not generate the entire tertiary
structure. These servers only generated the 3D structure of the
LRR domain of Xa21. Similarly, PRC, PROSPECT2, FFAS-3D,
FFAS03, SP3, MUSTER, pGenTHREADER and wdPPAS failed to
predict 3D structures of the TM, JM and kinase domain regions
(Fig. S4†). Although, Modeller (version 9.15) and Sparks-X
generated the entire protein's 3D structures, patchy unpre-
dicted regions were present in the models. All these incomplete
3D models of Xa21 were discarded and no further investigation
was done on these incomplete structures.
Structure validation of models for multiple template
modeling approach
All themultiple template modeling tools modeled 1025 residues
of Xa21 (Fig. S5†). For AIDA and I-TASSER, the structure for theThis journal is © The Royal Society of Chemistry 2020LRR domain is moderately consistent with their respective
chosen domain templates. Raptor-X and Phyre2 intensive
modeling generated LRR and kinase domains which did show
moderate consistency but the TM domain remained as a single
thread like structure which is neither consistent with the
secondary structure predicted, nor similar to its template
structure. Only the HHpred server modeled all the domains of
Xa21, where consistency of each domain with its counterpart
template looks substantially better (Fig. 2a). Except for the
model from I-TASSER, all multiple template protein models
gave ERRAT value greater than 50 (accepted value). In the case
of Verify-3D, none of the models reached the threshold value
(>80%) except for the model from the HHpred server (87.18)
which indicates good AA compatibility with its own 3D struc-
ture. PROCHECK Ramachandran plot of the model generated
by the HHpred server showed that 99.2% of residues in the
model were in the allowed region (Table 1) suggesting that the
quality of the model is better than that of the others. TheMSA of
the LRRs were aligned with the modeled structure (Fig. 2b) for
atomic level validation using PyMOL. Based on which, three
LRR beta strands were selected (LRR2, LRR3 and LRR4) for
analysis. Then the polar contacts in the intra main chain were
observed and found to be within a reasonable distance (Fig. 2c).
Then the beta strand of LRR2 was depicted as a ball and stick
structure, which helped hide its side chain, that the atomic
distance between the two consecutive C-alpha atoms could be
measured; and it was measured to be 3.4 A (Fig. 2d), which
indicated that the C-alpha atoms on the beta strands were in
a good position (3.5 A).
The model generated by the HHpred server was further
validated using ProQ, ProSA, VADAR and MolProbity. The ProQ
server gave an LG score of 5.172 suggesting a very good quality
model (the requirement being a value greater than 4). The
MaxSub score from ProQ was 0.315, indicating also a good
quality model. All the scores of ProSA (Z-score 8.95), VADAR
(standard deviation of c1 pooled 0.25, mean H-bond energy
0.65, percentage of generously allowed U angles 1.6,
percentage of packing defects 1.65) and MolProbity (percentage
of bad bond length 0.33, percentage of bad bond angles 1.81
and Ramachandran plot outliers 1.1) (Fig. S6†) further sup-
ported that the Xa21 model generated by the HHpred server was
of good quality.
A closer investigation of the structural differences between
the nal 3D structure generated by HHpred server and other
structures generated by single template modeling approach was
carried out. The analysis revealed several gaps at different sites
in the model generated by 3D-JIGSAW, Geno3D, PRC, PROS-
PECT2, FFAS-3D, FFAS03, Sparks-X, pGenTHREADER, wdPPAS
tool and Swiss-Model (Fig. S4†), whereas these are absent in the
nal model generated by the HHpred server (Fig. S5†). Swiss-
model was taken into consideration for a detailed breakdown
of the sequence alignment used to develop the model, which
was provided in great details by the tool. The rst structural gap
was observed at AA LYS288-ILE289 region, while the second and
largest structural gap was found between ASP339 to THR348.
The third and fourth structural deviations were observed at
ARG422-LEU423 and MET501-ILE502 regions, respectivelyRSC Adv., 2020, 10, 15800–15814 | 15805
Fig. 2 (a) Template alignment and position for 3D modling of Xa21 using the HHpred server; (b) MSA of 23 LRR domains of Xa21; (c) cartoon
structure of three LRRs; (d) ball and stick representation of one beta sheet of Xa21 LRR showing the distance between two C-alpha atoms; (e) LRR

























































































View Article Online(Fig. S7a†). To investigate these deciencies, the model gener-
ated by Swiss-model was further analyzed, which revealed that
these gaps were consistent with the deviations in the alignment15806 | RSC Adv., 2020, 10, 15800–15814between the model and the template (Fig S7b†). The larger the
observed gap, the more was the deviation; which was not the
case with the HHpred generated model (Fig. S7c†) and otherThis journal is © The Royal Society of Chemistry 2020
Table 1 Structural validation of the Xa21 proteins modeled using
different Multiple Template Modeling approachesa




MFR AAR GAR DR
HHpred server 67.179 87.18 78.9 18.4 1.9 0.8
AIDA 57.231 78.99 78 18.9 2.1 1.1
I-TASSER E 72.68 50.9 35.6 8.2 5.3
Phyre2 (intensive) 56.284 67.71 74.9 19.7 3 2.4
Raptor-X 68.553 76.2 78.2 18.6 1.5 1.8
a V. 3D, Verify-3D; MFR, most favored region; AAR, additionally allowed

























































































View Article Onlinemultiple template modeling tools. This clearly represents the
advantages of multiple template modeling over single template
modeling of multi-domain large proteins with low target-
template sequence similarity. This has been described earlier
by Buenavista et al., where they suggested that the model quality
can be improved by multiple template modeling in the case of
low sequence similarity (<30%) of the protein with its
template.89 Considering the multi-domain nature of the Xa21
protein, identifying the best template combination for each
domain and incorporating this template information to the
HHpred server is the best method for modeling this protein.
In the case of plant PRRs, LRRs are usually 22–23 AAs in
length that stack onto each other to make the LRR domain.90
The LRR domain of Xa21 exhibits the same architecture of 23
LRRs each composed of 22–23 AAs (Table S3†). Again for the
LRR domain of Xa21, the predicted horse-shoe shaped structure
(Fig. 2e) is common for other LRRs like FLS2, BRI1 and
PSKR.14,31,91 Although LRR of BRI1, PSKR and RPK2 exhibit
island domains to facilitate the binding of the ligands,31,77,92,93
no such island domain was observed for Xa21.
Additionally, where LRRs play the key role in the binding of
PAMPs, there are very few studies related to the activation of the
transmembrane (TM), juxtamembrane (JM) and cytoplasmic
kinase domains.13 For EFR mediated immunity, the absence of
TM domain resulted in the loss of binding capacity to the PAMP
elf18, thus proving the necessity of this domain.94 The TM of
Xa21, which is mainly composed of an alpha helixes (Fig. 2f),
has a signicant role in transferring defense signals as the lack
of this domain results in partial resistance of the rice plants.75
The crystal structure of the cytoplasmic kinase domain was
solved for BRI1 and BAK1 which revealed the conformation of
the domain. Kinase domain of the PRR in most cases is located
adjacent to the TM domain, where there is an N-terminal lobe,
a nucleotide-binding site, and a C-terminal lobe.95,96 Our pre-
dicted Xa21 JM and kinase domains show a structural confor-
mation similar to that of BRI1 and BAK1, where the JM domain
is mainly composed of alpha helix and the kinase domain has
multiple alpha helixes and beta sheets, starting with an N-
terminal lobe, a C-terminal lobe, followed by an activation
loop (Fig. 2g).This journal is © The Royal Society of Chemistry 2020Both BRI1 and BAK1 kinase domains can trans-
phosphorylate each other upon phosphorylation which is
assumed to have a regulatory function.97–99 For Xa21, upon
binding of the PAMP, the kinase domain is being activated via
the JM domain which results in autophosphorylation and/or
transphosphorylation of the other several proteins down-
stream.100 Several key residues of the JM domain were found to
play an important role in transphosphorylation to stabilize and
activate the PRR Xa21, which are – Ser686, Thr688 and
Ser689.100,101 In addition, the kinase domain of the PRR Xa21
(Fig. 2h) interacts and transphosphorylates the XB3, a ubiquitin
ligase, which is required for the successful activation of pattern
triggered immunity in rice plants.102 Thr705 of the JM domain of
Xa21 was found to be the key residue for autophosphorylation,
as replacement of this residue resulted in Xa21 being non-
interactive with other essential proteins – XB3, XB10, XB15
and XB24 – required for Xa21 mediated immunity.103Analysis of binding mode of Xa21 LRR with RaxX21-sY and
OsSERK2 LRR
The docking with Z-Dock shows that RaxX21-sY binds at the
lateral concave side of the LRR domain of Xa21 and Xa21 LRR,
RaxX21-sY and OsSERK2 LRR form heterodimer (Fig. 3, right
most). Other PRRs, such as FLS2, BRI1, PEPR1 and HAESA
showed the same binding mechanism with their respective
PAMPs. RaxX21-sY binds with Xa21 LRR 7–12, whereas for FLS2,
its PAMP g22 binds at the inner side (concave side) of the
outer-domain LRRs 3–18.14 In the case of receptor PEPR1, a 23
AA peptide AtPep1 binds at the inner surface of the ectodomain
LRRs 4–18 of PEPR1.104 Moreover, the PRRs BRI1 and HAESA
showed the same binding conformation as Xa21 with their
PAMP brassinolide and IDA, respectively (Fig. 3).31,76,77
For an in-depth analysis of the interaction between these
proteins, the energy contribution of every single residue was
calculated and presented in MM/PBSA graphs (Fig. 4). It was
observed that, Lys159, Arg230, Lys233, Arg258 and Arg304 from
Xa21, and Val2 and Lys15 from RaxX21-sY played an important
role during the interaction, by forming MM energy for both
complex 1a and complex 3 (Fig. 4a). From Tables S5A and B,†
Arg304 of Xa21 shows maximum binding free energy for inter-
acting with RaxX21-sY which is 26.8115  0.1772 kJ mol1
(complex 1a) and19.3743 0.2091 kJmol1 (complex 3). Lys159
from Xa21 interacts with RaxX21-sY more favorably in complex 3
(24.4097 0.1063 kJ mol1), but other residues (Arg230, Lys233,
Arg258 and Arg304) show favorable interaction in complex 1a
(20.8768  0.1632 kJ mol1, 21.5039  0.1351 kJ mol1,
21.6513  0.1107 kJ mol1, 26.8115  0.1772 kJ mol1,
respectively) (Table S5a†). For RaxX21-sY, Val2 is interacting more
favorably with Xa21 in complex 1a (13.5344  0.0765 kJ mol1)
but Lys15 shows favorable interaction in complex 3 (14.3603 
0.5324 kJ mol1) (Table S5C†).
In addition, for the interaction between Xa21 with OsSERK2,
several residues contribute signicantly to binding energy that
are – Arg61, Arg138, Lys159, Arg185, Arg230 and Lys233 for
Xa21; and Asp47, Asp80, Lys164, Lys183 and Arg212 for
OsSERK2 (Fig. 4b). Lys183 of OsSERK2 shows maximumRSC Adv., 2020, 10, 15800–15814 | 15807
Fig. 3 (a) Surface and cartoon structures of LRR-RK signaling complexes: FLS2-flg22-BAK1 (PDB ID 4mn8), BRI1-brassinolide-SERK1 (PDB ID
4lsx), PEPR1-AtPEP1 (PDB ID 5gr8), HAESA-IDA-SERK1 (PDB ID 5iyx) and Xa21-RaxX21-sY-OsSERK2. Receptors are shown in purple surface view,
PAMP/ligands are shown in blue surface view and the co-receptors ectodomains are shown in green as cartoon structure; (b) cartoon structures

























































































View Article Onlinebinding free energy when it interacts with Xa21 which is
50.0972  0.2914 kJ mol1 in complex 1b and 32.3350 
0.2338 kJ mol1 in complex 2 (Table S5D†). In both cases,
electrostatic interaction is more prominent than van der Waals
interaction.
Protein Interaction Calculator (PIC) online server was
employed to analyze the residues involved in interactions both
before and aer the MD simulation. For the Xa21 and RaxX21-
sY interaction, the residues which were found to be the most
active from the MM/PBSA calculation, showed participation in
different interactions both before and aer the simulation
process. Most of the residues of RaxX21-sY make strong bonds
with Xa21 LRR (Fig. 5a and b) and binds at the inner concave
side of the Xa21 LRR to form a sandwich between Xa21 and
OsSERK2 (Fig. 5c and d). Val2 forms the protein–protein main
chain-side-chain hydrogen bond interaction (Asn331, Phe354,Fig. 4 Comparative graphical representation of total binding energy obta
and (b) complex 1b and complex 3 for 100 ns. In (a) red color represents
color represents complex 1b and purple color represents complex 2.
15808 | RSC Adv., 2020, 10, 15800–15814Ala356, Glu358, and Tyr380) as well as hydrophobic interaction
with Xa21 (Tyr301) in both complex 1 and complex 3, and Lys15
from RaxX21-sY participates in ionic interactions with Glu358
and Glu407 of Xa21 (Tables S6D and Q†). Similarly, for Xa21,
only Arg230 plays a vital role participating in different interac-
tions (mostly ionic interactions) with Asp6 of RaxX21-sY both
before and aer the simulation (Tables S6B, D and Q†).
Again, for the Xa21 and OsSERK2 interaction (complex 1),
Arg185 and Arg230 of Xa21 participate in protein–protein main
chain-side chain and side chain-side chain hydrogen bond
formation with OsSERK2 residues (Asn50, Leu52, Asp56 and
His67) both before and aer the simulation (Tables S6A and
B†). From OsSERK2 only Lys164 participates in an ionic inter-
action with Asp565 from Xa21 before and aer the simulation.
But in complex 2, Lys164 of OsSERk2 participates in a protein–ined fromMM/PBSA calculation between (a) complex 1a and complex 3
complex 1a and cyan color represents complex 3, where in (b) green
This journal is © The Royal Society of Chemistry 2020
Fig. 5 Binding pattern of all residues of PAMP RaxX21-sY (cyan) with Xa21 LRR (purple) and co-receptor OsSERK2 (green). Here, (a) represents
binding pattern ten residues of PAMP RaxX21-sY (cyan) with Xa21 LRR (purple) and co-receptor OsSERK2 (green); (b) binding pattern of rest of
eleven residues of PAMP RaxX21-sY (cyan) with Xa21 LRR (purple) and co-receptor OsSERK2 (green); (c) binding groove visualization of ten
residues of PAMP RaxX21-sY (cyan) with surface structure of Xa21 LRR (purple); (d) binding groove visualization of rest of eleven residues of PAMP

























































































View Article Onlineprotein main chain-main chain hydrogen bond formation with
Thr567 of Xa21 aer the simulation (Table S6G†).
RMS uctuation (RMSF) of different complexes
The RMSFs of the residues of Xa21, RaxX21-sY and OsSERK2 for
all the simulated complexes were calculated from the 100 nsMD
trajectories. The overall results revealed that most of the resi-
dues uctuated by less than 0.50 nm for Xa21 and RaxX21-sY,
and 0.30 nm for OsSERK2. Furthermore, the least amount of
uctuation was displayed by the residues of Xa21 (Lys159,
Arg230, Lys233, Arg258 and Arg304) that gave the most favor-
able MM/PBSA values, in both complex 1a and 3 (Fig. 6a).
Arg230 of Xa21 was found to be the most prominent residue
in the MM/PBSA calculation, showed the lowest uctuation
(0.17 nm) in complex 1, as well as the second-lowest uctuation
(0.20 nm) in complex 3. On the other hand, the residues of Xa21
that uctuated the most are Gln20 (0.57 nm) and Gln541 (0.53)
for both complex 1 and complex 3 (Fig. 6a). In the case of
RaxX21-sY, Val2 showed the lowest RMSF value of 0.13 nm in
complex 1 and a slightly raised value of 0.14 nm in complex 3.
Another low uctuating residue of RaxX21-sY is Lys15 with
0.21 nm in complex 1 and 0.3 nm in complex 3.
When it comes to the Xa21 and OsSERK2 interaction, Arg61,
Arg138, Lys159, Arg185, Arg230, Lys233 of Xa21 showed
considerably low uctuations in both complex 1 and complex 2.
The MM/PBSA calculation also revealed that these same resi-
dues contributed more energy for interacting with OsSERK2. In
addition, Arg185 of Xa21 gives the lowest RMSF value both in
complex 1 and complex 2 (0.21 nm and 0.27 nm, respectively)
(Fig. 6a), which further supports the results of the MM/PBSA
calculation. The residues of Xa21 that uctuated the most in
this case were Arg49 and Gln541.This journal is © The Royal Society of Chemistry 2020Similarly, for OsSERK2, the residues (Asp47, Asp80, Lys164,
Lys183 and Arg212) that had higher energy contribution in the
MM/PBSA calculation also gave RMSF values that uctuated the
least in contrast to the other residues of OsSERK2 (Fig. 6b).
Among these residues, Lys164 gave the lowest uctuation value
both in complex 1 (0.16 nm) and in complex 2 (0.2 nm) (Fig. 6b).
Determination of the prominent residues of Xa21 LRR,
RaxX21-sY and OsSERK2 LRR
From the overview of MM/PBSA calculations along with an in-
depth analysis of the energy contribution of every single
residue, PIC data, and RMSF values, some residues can be
identied as the major players in the interactions to occur
between Xa21, RaxX21-sY and OsSERK2.
For the interaction between Xa21 and RaxX21-sY, Arg230 of
Xa21 seems to be this residue as displayed by – the highest MM
energy contribution (51.2735 kJ mol1 and 45.8491 kJ mol1
for complex 1a and complex 3, respectively), the lowest RMS
uctuation, the lowest non-polar energy (Table S5A†), partici-
pation in hydrogen bond formation, having hydrophobic
interaction and showing electrostatic energy for rising binding
affinity with RaxX21-sY (Table S5A†).
When the same analysis of the interactions between Xa21
and OsSERK2 is carried out, Arg185 is found to be the most
prominent in every aspect (MM/PBSA, PIC and RMSF calcula-
tion). In complex 1b, it gives 113.5355 kJ mol1 MM energy
(which primarily comes from electrostatic energy and few
contributions from van der Waals energy) and in complex 2, it
shows 74.7709 kJ mol1 MM energy which is the highest
compared to the other residues of Xa21 (Table S5B†). Moreover,
Arg185 of Xa21 also participates in hydrogen bond formation
(protein–protein main chain-side chain hydrogen bond,RSC Adv., 2020, 10, 15800–15814 | 15809
Fig. 6 RMS fluctuation of the residues from 100 ns trajectories. (a) RMSF of Xa21 LRR domain, where complex 1 is plotted as green and complex 2
is plotted as red, and complex 3 is plotted as blue; (b) RMSF of co-receptor OsSERK2 LRR domain, where complex 1 is plotted as green and

























































































View Article Onlineprotein–protein side chain-side chain hydrogen bond) with low
RMS uctuation besides the residue Arg230 (Tables S6A and I†).
For RaxX21-sY, though Lys15 contributed more MM energy
for interacting with Xa21, Val2 participates in more interactions
(protein–protein main chain-side chain hydrogen bond,
hydrophobic interaction) with Xa21 (Table S5C†). Therefore,
both of these residues can be marked as being prominent
residues for the interaction with Xa21.
For OsSERK2, Lys164 showed dominance when interacting
with Xa21 with 85.3566 kJ mol1 MM energy which is higher
than any other residue of OsSERK2 in complex 1b. In complex 2,
the MM energy of Lys164 is 53.8833 kJ mol1 (Table S5D†),
which is also high compared to the other residues of OsSERK2.
While showing a low RMS uctuation value, Lys164 also
participates in an ionic interaction with Asp565 of Xa21 (Table
S6D†) which makes this residue a strong candidate for being
a prominent residue.
Therefore, from Xa21 Arg230 and Arg185, from RaxX21-sY
Val2 and Lys15, and Lys164 of OsSERK2 are the most vital
residues when establishing interactions between these threeFig. 7 Prominent residues of Xa21 LRR, RaxX21-sY and OsSERK2 LRR. (
(deep purple), RaxX21-sY (cyan) and OsSERK2 (light green); (b) surface str
sY (cyan) and OsSERK2 (light green).
15810 | RSC Adv., 2020, 10, 15800–15814proteins (Fig. 7). Though there are other important residues but
in terms of the contribution of van der Waals energy, electro-
static energy, hydrogen bond formation, hydrophobic interac-
tions as well as cation–pi interaction these ve residues play the
most important role in Xa21 mediated pattern triggered
immune complex formation. Thus, it can be hypothesized that
a mutation at these residues can greatly affect the plant's ability
to trigger pattern triggered immunity.Contribution of PAMP RaxX21-sY and co-receptor OsSERK2 in
Xa21 mediated PTI
From the MM/PBSA calculation (Table 2), the binding energies
of complex 1b and complex 1a are 174.911 kJ mol1 and
45.093 kJ mol1, respectively. Besides these interactions,
binding energy of complex 2 is 181.920 kJ mol1, which is
more than the value of complex 1b. But an interaction seems
unlikely for complex 3 as its binding energy is 10.341 kJ mol1.
Moreover, in complex 3, polar solvation energy is high which
makes RaxX21-sY non-interactive with Xa21. From thisa) Cartoon and stick structure of the prominent residues of Xa21 LRR
ucture of the Xa21 LRR (deep purple), and cartoon structure of RaxX21-
This journal is © The Royal Society of Chemistry 2020







Complex 1a 240.860  25.595 385.813  77.663 611.431  91.031 29.851  2.788 45.093  52.964
Complex 1b 286.898  42.162 606.797  116.533 756.621  157.705 37.836  7.553 174.911  110.390
Complex 1c 96.581  30.324 85.388  55.586 233.675  97.856 11.581  3.934 40.124  67.288
Complex 2 403.270  91.270 676.877  205.008 946.819  278.196 48.592  10.988 181.920  135.765
Complex 3 250.508  30.032 362.350  86.456 653.408  119.333 30.210  2.657 10.341  66.370
a van der Waals energy. b Electrostatic energy. c Polar solvation energy. d Solvent Accessible Surface Area (SASA) energy. e Binding free energy. Every
simulation is performed for 100 ns. Here complex 1a shows interaction between Xa21 and RaxX21-sY when OsSERK2 is present inside the complex,
complex 1b shows interaction between Xa21 and OsSERK2 when RaxX21-sY is present and complex 1c for interaction between RaxX21-sY and
OsSERK2 when Xa21 is present. Complex 2 indicates the interaction of Xa21 and OsSERK2 in the absence of RaxX21-sY and complex 3 shows

























































































View Article Onlineoverview, it can be concluded that, co-receptor OsSERK2 plays
a signicant role for interactions to occur between Xa21 and
RaxX21-sY. On the other hand, when it comes to complex 2, the
high intermolecular electrostatic energy (Table 2) and MM/
PBSA values in contrast to complex 1b suggests that Xa21 can
interact with OsSERK2 both in the presence or absence of
RaxX21-sY.
In the case of pattern triggered immunity, most PAMPs recruit
one or multiple co-receptors and act as a molecular glue to form
a heterodimeric complex of PRR, co-receptor and PAMP. For BRI1,
co-receptor SERK1 is being recruited by ligand brassinolide,
which initiates the heterodimerization process.31 The PSKR-
phytosulfokine-SERK1 complex shows the same binding mecha-
nism as BRI1 mediated complex.13,105 In addition, in the presence
of PAMP IDA, the co-receptor SERK1 binds with HAESA whereas
in the absence of IDA the ectodomains of HAESA and SERK1 do
not interact with each other.76 For FLS2mediated immunity, g22
acts as a molecular glue for binding co-receptor BAK1.14
Our results show a different pattern of PAMP contribution
compared to most of the PTI complexes described above, as the
co-receptor OsSERK2 can bind with PRR Xa21 independent of
the presence of RaxX21-sY. The previous study on OsSERK2
proved that co-receptor OsSERK2 can frequently bind with PRR
Xa21 without the presence of RaxX21-sY27 and therefore
supports our result. Moreover, our study shows that Xa21
interacts more favorably with OsSERK2 without the presence of
RaxX21-sY with binding energy 181.920 kJ mol1.
Though for BRI1, ligand is needed for heterodimerization, it
can form homodimer without the presence of ligand brassino-
lide.99 This PAMP's binding to the preformed complexes stabi-
lize the ectodomains of the receptors and activates the kinase
domain.106 The necessity of these preformed complexes is well
dened in the case of receptor tyrosine kinases (RTKs), toll-like
receptors (TLRs) and cytokine receptors.107–109
Again, one of the key principles of binding for PAMPs is their
direction with respect to the PRR's ectodomains. The PAMP and
the LRR domain are either oriented in the same direction or in
the complete opposite direction.13,110,111 In our case, although
the structure of RaxX21-sY is slightly different from other
PAMPs, it can be said from the docking results that, RaxX21-sY
binds inversely with the Xa21 LRR. His1 (N-terminus residue) of
RaxX21-sY binds with Asn331, Asn335, Leu359 and Glu358 ofThis journal is © The Royal Society of Chemistry 2020Xa21 whereas Arg21 (C-terminus residue) of RaxX21-sY binds
with Glu231, Asp253, Gly255 and Tyr279 of Xa21 (Fig. 5).
Conclusion
This study depicts the in-depth computational modeling of an
entire plant PRR-Xa21, and its interaction with PAMP RaxX21-sY
and co-receptor OsSERK2 during pattern triggered immunity.
Results from different modeling approaches used in this study
suggest that a new multiple template approach using the
HHpred server described in this paper, is the best for modeling
the plant PRR protein Xa21. Likewise, the free energy binding
calculation fromMM/PBSA uncovers that Arg230 and Arg185 (of
Xa21 LRR), Val2, and Lys15 (of RaxX21-sY) and Lys164 (of
OsSERK2 LRR) are the key residues which contribute the most
in the interaction during PTI. Whether a mutation to these
residues affects the rice plants' ability to recognize the PAMP
RaxX21-sY is yet to be tested. Another notable nding of this
research is the contribution of the co-receptor OsSERK2 when
PRR Xa21 interacts with its PAMP RaxX21-sY during PTI. The
binding energy between Xa21 LRR and RaxX21-sY is more
prominent when OsSERK2 is present in the complex, but in its
absence, the energy count is quite low, making interactions
between them much less likely. Moreover, this study reveals
that Xa21 can interact with co-receptor OsSERK2 even without
the presence of PAMP RaxX21-sY, which supports the previous
result of heterodimer formation between Xa21 and OsSERK2 in
the absence of RaxX21-sY. Though this study exhibits that the
interaction between Xa21 and OsSERK2 is more prominent
without the presence of RaxX21-sY, a wet-lab experiment needs
to be carried out to prove this in silico result. As only a crystal-
lographic heterodimer complex of Xa21-RaxX21-sY-OsSERK2
can ascertain the more functional and structural aspects of
PTI mediated by Xa21. We strongly believe that all these nd-
ings will contribute signicantly to the scientic community
and enable further study to understand the facets of Xa21
mediated immunity and, overall, the rst layer of the plant
defense mechanism.
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and J. D. Jones, Plant Physiol., 2005, 138, 611–623.
12 S.-H. Shiu, W. M. Karlowski, R. Pan, Y.-H. Tzeng,
K. F. Mayer and W.-H. Li, Plant Cell, 2004, 16, 1220–1234.
13 U. Hohmann, K. Lau andM. Hothorn, Annu. Rev. Plant Biol.,
2017, 68, 109–137.
14 Y. Sun, L. Li, A. P. Macho, Z. Han, Z. Hu, C. Zipfel,
J.-M. Zhou and J. Chai, Science, 2013, 342, 624–628.
15 C. Dardick and P. Ronald, PLoS Pathog., 2006, 2(e2), 14–28.
16 C. Dardick, B. Schwessinger and P. Ronald, Curr. Opin.
Plant Biol., 2012, 15, 358–366.
17 T. Kawai and S. Akira, Int. Immunol., 2009, 21, 317–337.
18 G.-L. Wang, W.-Y. Song, D.-L. Ruan, S. Sideris and
P. C. Ronald, Mol. Plant-Microbe Interact., 1996, 9(9), 850–
855.
19 S. Ishiyama, Report of the Imperial Agricultural Station,
Nishigahara, Konosu, 1922, vol. 45, pp. 233–261.
20 J. Swings, M. Van den Mooter, L. Vauterin, B. Hoste,
M. Gillis, T. Mew and K. Kersters, Int. J. Syst. Evol.
Microbiol., 1990, 40, 309–311.
21 T. Mew, Annu. Rev. Phytopathol., 1987, 25, 359–382.
22 D. O. Niño-Liu, P. C. Ronald and A. J. Bogdanove,Mol. Plant
Pathol., 2006, 7, 303–324.
23 W. Pinta, T. Toojinda, P. Thummabenjapone and
J. Sanitchon, Afr. J. Biotechnol., 2013, 12, 4432–4438.15812 | RSC Adv., 2020, 10, 15800–1581424 W.-Y. Song, G.-L. Wang, L.-L. Chen, H.-S. Kim, L.-Y. Pi,
T. Holsten, J. Gardner, B. Wang, W.-X. Zhai and
L.-H. Zhu, Science, 1995, 270, 1804–1806.
25 R. N. Pruitt, B. Schwessinger, A. Joe, N. Thomas, F. Liu,
M. Albert, M. R. Robinson, L. J. G. Chan, D. D. Luu and
H. Chen, Sci. Adv., 2015, 1, e1500245.
26 M. Mubassir, M. A. Naser, M. F. Abdul-Wahab and
S. Hamdan, J. Chem. Pharm. Sci., 2019, 12(2), 121–126.
27 X. Chen, S. Zuo, B. Schwessinger, M. Chern, P. E. Canlas,
D. Ruan, X. Zhou, J. Wang, A. Daudi and C. J. Petzold,
Mol. Plant, 2014, 7, 874–892.
28 B. Schwessinger, X. Li, T. L. Ellinghaus, L. J. G. Chan,
T. Wei, A. Joe, N. Thomas, R. Pruitt, P. D. Adams and
M. S. Chern, Integr. Biol., 2016, 8, 542–545.
29 T. Wei, M. Chern, F. Liu and P. C. Ronald, Mol. Plant
Pathol., 2016, 17, 1493–1498.
30 R. N. Pruitt, A. Joe, W. Zhang, W. Feng, V. Stewart,
B. Schwessinger, J. R. Dinneny and P. C. Ronald, New
Phytol., 2017, 215, 725–736.
31 M. Hothorn, Y. Belkhadir, M. Dreux, T. Dabi, J. P. Noel,
I. A. Wilson and J. Chory, Nature, 2011, 474, 467–471.
32 T.-L. Jinn, J. M. Stone and J. C. Walker, Genes Dev., 2000, 14,
108–117.
33 T. Sindhu and P. Srinivasan, Mol. BioSyst., 2015, 11, 1305–
1318.
34 E. Gasteiger, C. Hoogland, A. Gattiker, M. R. Wilkins,
R. D. Appel and A. Bairoch, in The proteomics protocols
handbook, Springer, 2005, pp. 571–607.
35 L. J. McGuffin, K. Bryson and D. T. Jones, Bioinformatics,
2000, 16, 404–405.
36 C. Geourjon and G. Deleage, Bioinformatics, 1995, 11, 681–
684.
37 A. Armon, D. Graur and N. Ben-Tal, J. Mol. Biol., 2001, 307,
447–463.
38 S. Hunter, R. Apweiler, T. K. Attwood, A. Bairoch,
A. Bateman, D. Binns, P. Bork, U. Das, L. Daugherty and
L. Duquenne, Nucleic Acids Res., 2008, 37, D211–D215.
39 J. Schultz, F. Milpetz, P. Bork and C. P. Ponting, Proc. Natl.
Acad. Sci. U. S. A., 1998, 95, 5857–5864.
40 V. Offord, T. Coffey and D. Werling, Dev. Comp. Immunol.,
2010, 34, 1035–1041.
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